PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Readmission rate high for adults hospitalized for diabetic ketoacidosis

Readmitted patients with type 1 diabetes have two times the death rate during second hospitalization

2021-03-21
(Press-News.org) WASHINGTON--One in five adults with type 1 diabetes who require in-hospital treatment of the life-threatening condition diabetic ketoacidosis has an unplanned repeat hospital visit within a month and is twice as likely to die during the second hospitalization, a new study finds. The results, which will be presented at ENDO 2021, the Endocrine Society's annual meeting, also identified several factors that increased the readmission risk for these patients.

Diabetic ketoacidosis, which can occur from insufficient insulin medicine or from an infection, is a dangerous accumulation of acid in the blood due to excess glucose, or blood sugar. When severe, DKA can require hospitalization for fluid replacement and insulin therapy.

"Diabetic ketoacidosis is a feared complication of type 1 diabetes because it can lead to a diabetic coma and death," said the study's lead author, Hafeez Shaka, M.D., an internal medicine resident at John H. Stroger Jr. Hospital of Cook County, Chicago. "But we were surprised to find that the readmission rate after diabetic ketoacidosis treatment is so high."

For adults with type 1 diabetes who received diabetic ketoacidosis treatment in a hospital, the researchers studied the 30-day readmission rate and the factors that raised the risk of hospital readmission. They used a nationally representative data bank, the National Readmissions Database (NRD), the largest all-insurance payer database in the country, according to the Healthcare Cost and Utilization Project, the program that operates it.

Using the 2017 NRD database, Shaka and his colleagues found that 91,401 diabetic ketoacidosis-related hospitalizations involved adults with type 1 diabetes who were alive at discharge from the hospital. The rate of 30-day readmissions primarily due to diabetic ketoacidosis was 20.2 percent, involving 18,553 patients, he reported.

Women were more likely than men to be readmitted, as were patients who left the hospital against medical advice during the first admission. Other risk factors for readmission included having anemia, high blood pressure or chronic kidney disease, Shaka said.

Why women have higher rates of readmission is unclear, Shaka said. For patients who leave the hospital against medical advice, he speculated that they likely do not receive the education about blood sugar control and managing other medical conditions that they would typically get at discharge.

One reason for the high overall readmission rate could be that patients do not follow up with their diabetes care provider for glucose management, Shaka suggested. Individuals who experience diabetic ketoacidosis are at high risk of repeated episodes, he added.

The patients' subsequent admissions not only led to double the chance of in-hospital deaths compared with the first hospitalization. The researchers also found that repeated admissions were, on average, longer and generated significantly higher health care costs.

"Efforts should be channeled toward identifying the risk factors for readmission in hospitalized adult patients with diabetic ketoacidosis as well as ensuring proper discharge planning to decrease the burden of readmissions," Shaka said.

INFORMATION:

Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world's oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.

The Society has more than 18,000 members, including scientists, physicians, educators, nurses and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at http://www.endocrine.org. Follow us on Twitter at @TheEndoSociety and @EndoMedia.



ELSE PRESS RELEASES FROM THIS DATE:

Weekly insulin helps patients with type 2 diabetes achieve similar blood sugar control to daily insulin

2021-03-21
WASHINGTON--A new once-weekly basal insulin injection demonstrated similar efficacy and safety and a lower rate of low blood sugar episodes compared with a daily basal insulin, according to a phase 2 clinical trial. The study results, which will be presented at ENDO 2021, the Endocrine Society's annual meeting, compared an investigational drug called basal insulin Fc (BIF) with insulin degludec, a commercially available long-lasting daily insulin, in patients with type 2 diabetes. "These study results demonstrate that BIF has promise as a once-weekly basal insulin and could be an advancement in insulin therapy," ...

COVID-19 can cause atypical thyroid inflammation

2021-03-20
WASHINGTON--Some patients with moderate to severe COVID-19 disease seem to experience inflammation of the thyroid gland that is different from thyroid inflammation caused by other viruses, according to a study presented virtually at ENDO 2021, the Endocrine Society's annual meeting. One-third of the study participants still had signs of thyroid inflammation after three months, even though their thyroid function had normalized. The study is following patients to determine whether this inflammation will trigger permanent thyroid dysfunction. In spring 2020, 15 percent of the COVID-19 patients hospitalized in acute medicine units ...

Hospitalized COVID-19 patients with obesity are significantly more likely to need ICU care

2021-03-20
WASHINGTON--People with obesity who are hospitalized with COVID-19 have a significantly higher rate of ICU admissions and longer duration of ICU stay compared to people with a normal body mass index (BMI), according to a study presented virtually at ENDO 2021, the Endocrine Society's annual meeting. "The association between obesity and a more severe clinical course of COVID-19 highlights the vulnerability of this population during the current pandemic and the need for public health efforts to prevent and treat obesity, in the current pandemic and beyond," said lead researcher Yu Mi Kang, M.D., Ph.D., of Yale New Haven ...

Poor diabetes control in children tied to high risk for COVID-19 complications, death

2021-03-20
WASHINGTON--Children with poorly controlled type 1 diabetes have a 10 times higher risk of COVID-19-related complications and death compared to those with well-controlled diabetes, according to a study presented virtually at ENDO 2021, the Endocrine Society's annual meeting. "This study shows keeping diabetic children's blood sugar under control is more important than ever during the pandemic," said lead author Manish Raisingani, M.D., of the University of Arkansas for Medical Sciences and Arkansas Children's in Little Rock, Ark. "The findings will help children with type 1 diabetes and their families make better choices about the safety of attending school in person and engaging ...

Common drugs for type 2 diabetes and obesity do not increase breast cancer risk

2021-03-20
WASHINGTON--Commonly used medications for type 2 diabetes and obesity called glucagon like peptide-1 receptor agonists (GLP-1 RAs), are not associated with an increased risk of breast cancer, despite previous studies that suggested a possible link, according to a study presented virtually at ENDO 2021, the Endocrine Society's annual meeting. "GLP-1RAs can be used as adjunct to diet and exercise in subjects with type 2 diabetes and those without type 2 diabetes and excess weight, without an increased risk of breast cancer or noncancerous masses in the breast," said lead researcher Giovana Fagundes Piccoli, M.D., of the Universidade Federal do Rio Grande do Sul in Brazil. GLP-1 RAs have been shown to be effective in treating obesity and type 2 diabetes ...

Genetic evidence suggests men can develop PCOS-like condition

2021-03-20
WASHINGTON--New genetic research suggests men can develop characteristics of polycystic ovary syndrome (PCOS)--a common metabolic and reproductive disorder that affects women. The study was presented virtually at ENDO 2021, the Endocrine Society's annual meeting. PCOS is a common disorder characterized by irregular menstrual periods, disruption of normal metabolism and elevated testosterone levels. PCOS affects up to 10% of all women of reproductive age. The disorder can lead to obesity, diabetes and cardiovascular disease, which are often life-long conditions. Men who have genetic risk factors ...

Sleep disturbances may contribute to weight gain in menopause

2021-03-20
WASHINGTON--Addressing sleep symptoms during menopause may reduce susceptibility to weight gain, according to a small study presented virtually at ENDO 2021, the Endocrine Society's annual meeting. "Our findings suggest that not only estrogen withdrawal but also sleep disturbances during menopause may contribute to changes in a woman's body that could predispose midlife women to weight gain," said lead researcher Leilah Grant, Ph.D., of Brigham and Women's Hospital in Boston, Mass. "Helping women sleep better during menopause may therefore reduce the chances ...

Largest-ever analysis of its kind finds Cushing's syndrome triples risk of death

2021-03-20
WASHINGTON--Endogenous Cushing's syndrome, a rare hormonal disorder, is associated with a threefold increase in death, primarily due to cardiovascular disease and infection, according to a study whose results will be presented at ENDO 2021, the Endocrine Society's annual meeting. The research, according to the study authors, is the largest systematic review and meta-analysis to date of studies of endogenous (meaning "inside your body") Cushing's syndrome. Whereas Cushing's syndrome most often results from external factors--taking cortisol-like medications such as prednisone--the endogenous type occurs when the body overproduces the hormone cortisol, affecting multiple bodily ...

Many endocrine patients, providers want to continue telehealth after pandemic

2021-03-20
WASHINGTON--Two-thirds of patients with chronic endocrine health problems who need close monitoring say they would like to continue with telemedicine follow-up visits after the COVID-19 pandemic ends, according to a survey that will be presented virtually at ENDO 2021, the Endocrine Society's annual meeting. Three-quarters of providers also said they want to continue with telehealth after the pandemic. "Endocrinology clinics have significant number of patients who need long-term close follow-up for medication adjustments, symptom checks and counseling," said lead researcher Maryam Nemati, M.D., of San Joaquin General Hospital in French Camp, Calif. "Our ...

Combination thyroid hormone therapies treat hypothyroidism as well as levothyroxine

2021-03-20
WASHINGTON--Treatment of hypothyroidism, which results from an underactive thyroid gland, should be individualized and consideration should be given to alternatives to the first-line therapy, including desiccated thyroid extract and combination therapy to replace the body's two main thyroid hormones, thyroxine (T4) and triiodothyronine (T3). Results of their new randomized clinical study are being presented at ENDO 2021, the Endocrine Society's annual meeting. Combination therapy has been shown to be equally as effective as the standard treatment with levothyroxine alone, researchers say. "There are now proven good treatment options for the more than one in 10 patients with hypothyroidism who continue to experience symptoms of fatigue, mental fogginess, weight ...

LAST 30 PRESS RELEASES:

Simple and cost-effective reporter assay for evaluating chemical-induced epigenetic changes

Scientists say the “plant world” needs to come out and claim its place at the One Health table

A new tool to improve lives after brain injury is underway at The University of Texas at San Antonio

Guinea pigs: A promising animal model to study the human embryo

The rise of "gut feelings" in US political rhetoric

How mothers adapt to the metabolic demands of nursing

Caspian Sea decline threatens endangered seals, coastal communities and industry

Landmark study identifies new genetic cause of neurodevelopmental disorders, bringing long-awaited answers to families

Scientists create “metal detector” to hunt down tumors

New USC study identifies key brain networks behind post-stroke urinary incontinence

Hidden potential in multiple disabilities

How to protect bumblebee colonies safe from killer moths? Keep honeybee hives away from them

Rolling particles make suspensions more fluid

Research fine tunes tools used to search for genetic causes of asthma

Meditation and critical thinking are the ‘key to meaningful AI use’

Studies shows new class of antibiotic is effective in tackling MRSA

Certain nasal bacteria may boost the risk for COVID-19 infection, study finds

Europe's population is adapting better to cold than to heat

Ancient tools from a South African cave reveal connections between prehistoric people

World’s first birth following conception with a fully automated remotely operated ICSI system

Girls’ education projects succeed when whole communities ‘live the change’ and carry it forward

European bird declines linked to range of climatic conditions experienced

'Hidden galaxies' could be smoking gun in universe riddle

Love songs in the sand: researchers listen in to Fiddler crab courtship

Study suggests lean muscle mass loss can be minimized during weight loss therapy using newer incretin obesity drugs

Aussie tech helps make bio-oils for greener industrial applications

Map of genetic regulation in chickens could help fight against bird flu

Scientists map unprecedented detail of connections and visual perception in the mouse brain

Mapping mercury contamination in penguins of the Southern Ocean

Engineer aims to make giant leap for welding materials on the moon

[Press-News.org] Readmission rate high for adults hospitalized for diabetic ketoacidosis
Readmitted patients with type 1 diabetes have two times the death rate during second hospitalization